On October 12, 2010
In $3.6B King Deal, Pfizer Gets a Small but Important EpiPen Monopoly
The $3.6B Pfizer-King deal ought to make management at Mylan, which sells the auto-injector EpiPen for severe allergies in a marketing rights deal with King, nervous.
No tags for this post.
0 Comments